View in EDS

RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.

Saved in:
Bibliographic Details
Title: RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.
Authors: Sango, Junya1,2,3,4,5 (AUTHOR), Carcamo, Saul1,2,3,4,5,6 (AUTHOR), Sirenko, Maria7,8 (AUTHOR), Maiti, Abhishek (AUTHOR), Mansour, Hager1,2,3,4,5 (AUTHOR), Ulukaya, Gulay1,2,3,4,5,6 (AUTHOR), Tomalin, Lewis E.2,3,4,5,6 (AUTHOR), Cruz-Rodriguez, Nataly1,2,3,4,5 (AUTHOR), Wang, Tiansu1,2,3,4,5 (AUTHOR), Olszewska, Malgorzata1,2,3,4,5 (AUTHOR), Olivier, Emmanuel1,2,3,4,5 (AUTHOR), Jaud, Manon1,2,3,4,5 (AUTHOR), Nadorp, Bettina9,10 (AUTHOR), Kroger, Benjamin11,12 (AUTHOR), Hu, Feng (AUTHOR), Silverman, Lewis2,4,5 (AUTHOR), Chung, Stephen S.11,13 (AUTHOR), Wagenblast, Elvin1,2,3,5 (AUTHOR), Chaligne, Ronan14,15 (AUTHOR), Eisfeld, Ann-Kathrin (AUTHOR)
Source: Nature. Oct2024, p1-10.
Database: Academic Search Ultimate
Description
ISSN:00280836
DOI:10.1038/s41586-024-08137-x